Myocardial ischemia in patients with dilated cardiomyopathy

Nuclear Medicine Communications

Volumn 31, Issue 11, 2010, Pages 981-984

  Fang, Wei ^a   Zhang, Jian ^a   He, Zuo Xiang ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

dilated cardiomyopathy; heart failure; left ventricular dysfunction; myocardial ischemia

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPYRIDAMOLE; ESMOLOL; FLUORODEOXYGLUCOSE F 18; NEBIVOLOL; PLACEBO;

BLOOD FLOW VELOCITY; CARDIAC PATIENT; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DISEASE COURSE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART VENTRICLE WALL MOTION; HUMAN; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; CORONARY CIRCULATION; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROGNOSIS;

EID: 77958007577     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833f393f     Document Type: Review

References (34)

1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113:1807-1816.
2. L'Abbate A, Sambuceti G, Neglia D. Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application. J Nucl Cardiol 2002; 9:328-337.
3. Neglia D, L'Abbate A. Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy. Pharmacol Rep 2005; 57 (Suppl):151-155.
4. Maron BJ,Wolfson JK, Epstein SE, Roberts WC. Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8:545-557.
5. Parodi O, De MR, Oltrona L, Testa R, Sambuceti G, Roghi A, et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 1993; 88:509-522.
6. Unverferth DV, Magorien RD, Lewis RP, Leier CV. The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. Am Heart J 1983; 105:176-179.
7. Yamaguchi S, Tsuiki K, Hayasaka M, Yasui S. Segmental wall motion abnormalities in dilated cardiomyopathy: hemodynamic characteristics and comparison with thallium-201 myocardial scintigraphy. Am Heart J 1987; 113:1123-1128.
8. O'Neill JO, McCarthy PM, Brunken RC, Buda T, Hoercher K, Young JB, Starling RC. PET abnormalities in patients with nonischemic cardiomyopathy. J Card Fail 2004; 10:244-249.
9. Chikamori T, Doi YL, Yonezawa Y, Yamada M, Seo H, Ozawa T. Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am J Cardiol 1992; 69:650-653.
10. Juilliere Y, Marie PY, Danchin N, Gillet C, Paille F, Karcher G, et al. Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy. Eur Heart J 1993; 14:1163-1169.
11. Tian Y, Liu X, Shi R, Liu Y, Wu Q, Zhang X. Radionuclide techniques for evaluating dilated cardiomyopathy and ischemic cardiomyopathy. Chin Med J (Engl) 2000; 113:392-395.
12. Isobe S, Ando A, Nanasato M, Nonokawa M, Izawa H, Sobue T, et al. Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy. Nucl Med Commun 2003; 24:1071-1080.
13. Hasegawa S, Kusuoka H, Maruyama K, Nishimura T, Hori M, Hatazawa J. Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers. J Am Coll Cardiol 2004;43:224-233.
14. Berk F, Isgoren S, Demir H, Kozdag G, Sahin T, Ural D, Kahraman G. Assessment of left ventricular function and volumes for patients with dilated cardiomyopathy using gated myocardial perfusion SPECT and comparison with echocardiography. Nucl Med Commun 2005; 26:701-710.
15. Van den Heuvel AF, Van Veldhuisen DJ, Van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2000; 35:19-28.
16. Morales MA, Neglia D, L'Abbate A. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study. J Cardiovasc Med (Hagerstown) 2008; 9: 778-782.
17. Neglia D, Sambuceti G, Iozzo P, L'Abbate A, Strauss HW. Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2002; 29:1403-1413.
18. Wang F, Zhang J, Fang W, Zhao SH, Lu MJ, He ZX. Evaluation of left ventricular volumes and ejection fraction by gated SPECT and cardiac MRI in patients with dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2009; 36:1611-1621.
19. Stolen KQ, Kemppainen J, Kalliokoski KK, Hallsten K, Luotolahti M, Karanko H, et al. Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy. J Card Fail 2004; 10:132-140. (Pubitemid 38858074)
20. Range FT, Paul M, Schafers KP, Acil T, Kies P, Hermann S, et al. Myocardial perfusion in nonischemic dilated cardiomyopathy with and without atrial fibrillation. J Nucl Med 2009; 50:390-396.
21. Skalidis EI, Parthenakis FI, Patrianakos AP, Hamilos MI, Vardas PE. Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004; 44:2027-2032.
22. Tio RA, Slart RH, De Boer RA, Van der Vleuten PA, De Jong RM, Van Wijk LM, et al. Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy. Neth Heart J 2009; 17:470-474.
23. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, et al. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2008; 52:1391-1398.
24. Davila-Roman VG, Vedala G, Herrero P, De LFL, Rogers JG, Kelly DP, Gropler RJ. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002; 40:271-277.
25. Neglia D, De CA, Marraccini P, Natali A, Ciardetti M, Vecoli C, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2007; 293:3270-3278.
26. Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure. J Nucl Med 2001; 42:55-62.
27. De Jong RM, Tio RA, Van der Harst P, Voors AA, Koning PM, Zeebregts CJ, et al. Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol 2009; 16:769-774.
28. He ZX, Shi RF, Wu YJ, Tian YQ, Liu XJ, Wang SW, et al. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation 2003; 108:1208-1213.
29. Jain D, He ZX. Direct imaging of myocardial ischemia: a potential new paradigm in nuclear cardiovascular imaging. J Nucl Cardiol 2008; 15:617-630.
30. Hara Y, Inoue K, Ogimoto A, Ohtsuka T, Shigematsu Y, Nakata S, Higaki J. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy. Cardiology 2005; 104:16-21.
31. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002; 105:186-193.
32. Erdogan D, Gullu H, Caliskan M, Ciftci O, Baycan S, Yildirir A, Muderrisoglu H. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Heart 2007; 93:319-324.
33. Skalidis EI, Hamilos MI, Chlouverakis G, Kochiadakis GE, Parthenakis FI, Vardas PE. Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2007; 100:1299-1302.
34. Neglia D, De Maria R, Masi S, Gallopin M, Pisani P, Pardini S, et al. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. Heart 2007; 93:808-813.